| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SYK | Common Stock | Sale | -$919K | -3.54K | -27.63% | $260.00 | 9.26K | Jan 9, 2023 | Direct | F1, F2 |
| transaction | SYK | Common Stock | Options Exercise | $130K | +1.4K | +15.08% | $93.06 | 10.7K | Jan 10, 2023 | Direct | |
| transaction | SYK | Common Stock | Options Exercise | $500K | +5.17K | +48.53% | $96.64 | 15.8K | Jan 10, 2023 | Direct | |
| transaction | SYK | Common Stock | Sale | -$297K | -1.16K | -7.31% | $256.49 | 14.7K | Jan 11, 2023 | Direct | F1, F3 |
| transaction | SYK | Common Stock | Sale | -$879K | -3.42K | -23.28% | $257.30 | 11.3K | Jan 11, 2023 | Direct | F1, F4 |
| transaction | SYK | Common Stock | Sale | -$363K | -1.4K | -12.46% | $258.45 | 9.86K | Jan 11, 2023 | Direct | F1, F5 |
| transaction | SYK | Common Stock | Sale | -$89.8K | -346 | -3.51% | $259.49 | 9.51K | Jan 11, 2023 | Direct | F1, F6 |
| transaction | SYK | Common Stock | Sale | -$30.3K | -116 | -1.22% | $261.12 | 9.4K | Jan 11, 2023 | Direct | F1, F7 |
| transaction | SYK | Common Stock | Sale | -$34.4K | -131 | -1.39% | $262.72 | 9.26K | Jan 11, 2023 | Direct | F1, F8 |
| holding | SYK | Common Stock | 342 | Jan 9, 2023 | By 401K |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SYK | Employee Stock Option granted 02/11/2015 (right to buy) | Options Exercise | $0 | -1.4K | -100% | $0.00* | 0 | Jan 10, 2023 | Common Stock | 1.4K | $93.06 | Direct | F9 |
| transaction | SYK | Employee Stock Option granted 02/10/2016 (right to buy) | Options Exercise | $0 | -5.17K | -100% | $0.00* | 0 | Jan 10, 2023 | Common Stock | 5.17K | $96.64 | Direct | F9 |
| Id | Content |
|---|---|
| F1 | The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 11, 2022. |
| F2 | Includes 26 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2022, the date of the latest available statement of the reporting person's ESPP holdings. |
| F3 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $255.81 to $256.78, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F4 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $256.85 to $257.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F5 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $257.855 to $258.82, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F6 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $259.105 to $259.65, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F7 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $260.46 to $261.23, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F8 | The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $262.67 to $263, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein. |
| F9 | Employee stock option granted pursuant to the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. |
Exhibit 24, Power of Attorney, is attached.